Financhill
Sell
19

CRSP Quote, Financials, Valuation and Earnings

Last price:
$42.12
Seasonality move :
6.36%
Day range:
$41.94 - $43.48
52-week range:
$36.52 - $75.91
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.87x
Volume:
1.4M
Avg. volume:
2.4M
1-year change:
-41.51%
Market cap:
$3.6B
Revenue:
$35M
EPS (TTM):
-$4.37

Earnings Data

Next earnings date for CRSP
May 08
2025
Most recent earnings per share
-$0.44
Beat by $0.75
(Feb 11/2025)
Consensus Estimate
-$1.19
(Feb 11/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CRSP Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/08/2025 Q1 $6.4M -- -- -$1.28 --
02/11/2025 Q4 $7.3M $35M -$0.44 -$1.19 $0.75
11/05/2024 Q3 $7.1M -- -$1.01 -$1.40 $0.39
08/05/2024 Q2 $13.6M -- -$1.49 -$1.42 -$0.07
05/08/2024 Q1 $26.5M -- -$1.43 -$1.46 $0.03
02/21/2024 Q4 $123.1M $200M $1.13 $0.05 $1.08
11/06/2023 Q3 -- -- -$1.41 -$1.95 $0.54
08/07/2023 Q2 -- -- -$0.98 -$2.10 $1.12
05/08/2023 Q1 -- -- -$0.67 -$1.64 $0.97
02/21/2023 Q4 -- -- -$1.41 -$2.27 $0.86
11/01/2022 Q3 -- -- -$2.24 -$2.24 -$0.00
08/08/2022 Q2 -- -- -$2.40 -$2.21 -$0.19
05/09/2022 Q1 -- -- -$2.32 -$1.97 -$0.35
02/16/2022 Q4 -- -- -$1.84 -$1.78 -$0.06
11/03/2021 Q3 -- -- -$1.67 -$1.76 $0.09
07/29/2021 Q2 -- -- $9.44 $3.12 $6.32
04/27/2021 Q1 -- -- -$1.51 -$1.47 -$0.04
02/16/2021 Q4 -- -- -$1.52 -$1.28 -$0.24
10/28/2020 Q3 -- -- -$1.32 -$1.19 -$0.13
07/27/2020 Q2 -- -- -$1.30 -$0.99 -$0.31
04/28/2020 Q1 -- -- -$1.15 -$1.04 -$0.11
02/12/2020 Q4 -- -- $0.51 $0.05 $0.46
10/28/2019 Q3 -- -- $2.40 $1.79 $0.61
07/29/2019 Q2 -- -- -$1.01 -$0.90 -$0.11
04/29/2019 Q1 -- -- -$0.93 -$0.90 -$0.03
02/25/2019 Q4 -- -- -$0.92 -- --
11/07/2018 Q3 -- -- -$1.07 -- --
08/07/2018 Q2 -- -- -$0.82 -- --
05/08/2018 Q1 -- -- -$0.62 -- --
03/08/2018 Q4 -- -- $0.01 -- --
11/08/2017 Q3 -- -- -$0.62 -- --
08/10/2017 Q2 -- -- -$0.56 -- --
03/31/2017 Q1 -- -- -$0.54 -- --
12/31/2016 Q4 -- -- $0.43 -- --
09/30/2016 Q3 -- -- -$0.37 -- --
06/30/2016 Q2 -- -- -$0.43 -- --
03/31/2016 Q1 -- -- -$0.29 -- --
12/31/2015 Q4 -- -- -$0.42 -- --
09/30/2015 Q3 -- -- -$0.22 -- --

CRISPR Therapeutics AG Earnings Questions

  • How Much did CRISPR Therapeutics AG Generate in Revenue Last Quarter?

    CRISPR Therapeutics AG reported $35M worth of top line sales in its most recent quarter.

  • Did CRISPR Therapeutics AG Beat Earnings Last Quarter?

    CRISPR Therapeutics AG announced earnings per share of -$0.44 which represents a beat of analyst forecast a -$1.19 per share.

  • Is CRISPR Therapeutics AG Profitable?

    CRISPR Therapeutics AG reported $35M that represents $0.41 per share over the last quarter.

  • What is the Analyst Consensus for CRISPR Therapeutics AG EPS Next Year?

    CRISPR Therapeutics AG's earnings are forecast to decrease from -$4.34 per share to -$5.12 per share next year representing a decrease of -12.39%.

  • When is CRISPR Therapeutics AG's Earnings Date?

    CRISPR Therapeutics AG's next earnings date is May 8, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Reddit a Buy on the Dip?
Is Reddit a Buy on the Dip?

Reddit (NYSE:RDDT) share price has been on the proverbial ropes…

Qualcomm Stock: 5G Leader at a Bargain Price?
Qualcomm Stock: 5G Leader at a Bargain Price?

Chip giant QUALCOMM Incorporated (NASDAQ:QCOM) was the ultimate chip company…

What Is Buffett Buying and Selling Now?
What Is Buffett Buying and Selling Now?

In Q4 of last year, Warren Buffett made a few…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
59
GRRR alert for Mar 15

Gorilla Technology Group [GRRR] is up 29.72% over the past day.

Sell
49
SMTC alert for Mar 15

Semtech [SMTC] is up 21.28% over the past day.

Buy
62
PLPC alert for Mar 15

Preformed Line Products [PLPC] is up 17.38% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock